Biosoft aims to become a conductor between fundamental science and services. It helps business representatives to find appropriate scientific partners.
VISION AND MISSION
Biosoft aims to put on stream fundamental science problems that phramaceutical and other lifesciences companies are forced to deal with in order to get a desired result.
The BioUML platform is certified and intellectual rights on it totally belong to the Biosoft company
Biosoft is totally responsible for the quality of all of the services it provides.
Our top management team unites experts in science and administration, that's why Biosoft is developing quickly and efficiently.
Biosoft has collected a team of real experts to grant you top quality scientific services.
Track the news on our web site as we have almost started the countdown to the very first public release of our workflow system "From genome to target" for automatized search of new therapeutic targets.
Come and join us on the grand opening of Biosoft's new office in Skolkovo Technopark on April 21st! You will find interesting lectures on bioinformatics, workshops and a hakaton on search for personalized biomarkers and drug targets on real patient's data.
Join us on April 13th if you are interested in molecular medicine and drug development, as we are going to give a webinar on the basic approach for searching for new drug targets and biomarkers.
Biosoft owns all the rights on the BioUML platform for biomedical data analysis. The intellectual property is guarded by the certificate of computer program registration, issued on 19th of June 2008 in Novosibirsk, Russia.